• 31-MAR-2015

  • SOURCE: Journal of the American Medical Association

Two Therapies To Treat Sickle Cell Disease Are Underutilized

Sickle cell disease is a life-threatening genetic disorder that affects nearly 100,000 individuals in the United States. The disease, which is associated with abnormalities in the red blood cells, can result in an array of serious health problems.

A panel of experts reviewed more than 30 years of studies on sickle cell disease, to create a new guideline for managing the disease. The report highlights two therapies, the use of the drug hydroxyurea and blood transfusions, that are effective but underutilized when it comes to treatment.